Literature DB >> 572801

Mechanisms responsible for antibody-dependent, cell-mediated cytotoxicity to isolated hepatocytes in chronic active hepatitis.

C Gonzales, A M Cochrane, A L Eddleston, R Williams.   

Abstract

Lymphocytes from patients with chronic active hepatitis have been found to be cytotoxic for isolated rabbit hepatocytes. Although this reaction has been shown to be of the antibody-dependent type, no autologous serum was added to the assay system and in the present experiments the source of the antibody has been sought. The failure of puromycin to block the reaction argued against a role for antibody synthesised during the culture period, and the demonstration that normal mononuclear cells could become cytotoxic when preincubated in chronic active hepatitis sera was more in favour of the passive acquisition of an antibody from the circulation. Evidence for the existence of free antibody in the sera reacting with hepatocyte surface antigens came from an additional series of experiments in which it was shown that preincubation of hepatocytes in chronic active hepatitis sera rendered them susceptible to damage by normal mononuclear cells. This effect was almost completely abolished by adding a membrane lipoportein fraction of human liver (LSP) to the sera during the preincubation step, suggesting that the LSP contained those antigens on the hepatocyte surface against which the majority of the antibodies were directed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 572801      PMCID: PMC1412433          DOI: 10.1136/gut.20.5.385

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Proceedings: Lymphocyte mediated cytotoxicity for Chang liver cells in acute and chronic liver disease.

Authors:  E Jacques; D De Villers; H C Thomas; S Sherlock
Journal:  Gut       Date:  1976-05       Impact factor: 23.059

2.  Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis.

Authors:  A D Thomson; M A Cochrane; I G McFarlane; A L Eddleston; R Williams
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

3.  An in vitro assay for cellular hypersensitivity in man.

Authors:  R E Rocklin; O L Meyers; J R David
Journal:  J Immunol       Date:  1970-01       Impact factor: 5.422

4.  Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease.

Authors:  A M Cochrane; A Moussouros; B Portmann; I G McFarlane; A D Thomson; R Williams
Journal:  Gastroenterology       Date:  1977-05       Impact factor: 22.682

5.  Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

Authors:  A M Cochrane; A Moussouros; A D Thomsom; A L Eddleston; R Wiiliams
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

6.  Purification and characterization of human liver-specific membrane lipoprotein (LSP).

Authors:  I G McFarlane; B M Wojcicka; G M Zucker; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

7.  Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome.

Authors:  A P Geubel; R H Keller; W H Summerskill; E R Dickson; T B Tomasi; R G Shorter
Journal:  Gastroenterology       Date:  1976-09       Impact factor: 22.682

8.  The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes.

Authors:  R D Hughes; A M Cochrane; A D Thomson; I M Murray-Lyon; R Williams
Journal:  Br J Exp Pathol       Date:  1976-06

9.  Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis.

Authors:  D M Jensen; I G McFarlane; B S Portmann; A L Eddleston; R Williams
Journal:  N Engl J Med       Date:  1978-07-06       Impact factor: 91.245

10.  Cell-mediated immunity in acute and chronic hepatitis.

Authors:  J R Wands; J L Perrotto; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

View more
  12 in total

Review 1.  Chronic active hepatitis.

Authors:  P J Johnson; I G McFarlane
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 2.  Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

Review 3.  Cellular mechanisms of hepatocyte damage and regulatory mechanisms in autoimmune chronic active hepatitis.

Authors:  S Vento; A L Eddleston
Journal:  Springer Semin Immunopathol       Date:  1990

Review 4.  Immunological aspects of chronic active hepatitis.

Authors:  S Vento; A L Eddleston
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

5.  Effect of polyunsaturated phosphatidylcholine on immune mediated hepatocyte damage.

Authors:  J Neuberger; J E Hegarty; A L Eddleston; R Williams
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

6.  Increased sensitivity to concanavalin A and a suppressor cell defect in chronic active hepatitis.

Authors:  C de Galocsy; P J Jenkins; G Mieli-Vergani; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

7.  Immune responses to liver membrane antigens in patients with cystic fibrosis and liver disease.

Authors:  G Mieli-Vergani; H T Psacharopoulos; A M Nicholson; A L Eddleston; A P Mowat; R Williams
Journal:  Arch Dis Child       Date:  1980-09       Impact factor: 3.791

8.  Antibodies to a human liver membrane lipoprotein (LSP) in primary biliary cirrhosis.

Authors:  D Tsantoulas; A Perperas; B Portmann; A L Eddleston; R Williams
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

9.  Autoantibody responses to liver-specific lipoprotein in mice.

Authors:  W N Bartholomaeus; W D Reed; R A Joske; K B Shilkin
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

10.  Autoantibodies to liver-specific lipoprotein following hepatitis induced by mouse cytomegalovirus.

Authors:  W N Bartholomaeus; G R Shellam; J E Allan; W D Reed; R A Joske
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.